Work

Risankizumab (Skyrizi) for Ulcerative Colitis

Year: 2024

Type: article

Source: The medical letter on drugs and therapeutics/The medical letter

DOI: 10.58347/tml.2024.1715d

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4403717127

FWCI:

Cites:

Cited by:

Related to: 10